KYORIN Pharmaceutical Co.,Ltd. ( (JP:4569) ) just unveiled an announcement.
KYORIN Pharmaceutical Co., Ltd. reported significant financial growth for the fiscal year ending March 31, 2025, with an 8.8% increase in net sales and a 101.6% rise in operating profit compared to the previous year. The company also announced a special dividend, reflecting its strong financial performance. However, the forecast for the upcoming fiscal year indicates a decline in net sales and profits, suggesting potential challenges ahead. Changes in accounting policies have been implemented, affecting the reported figures for the previous fiscal year.
More about KYORIN Pharmaceutical Co.,Ltd.
KYORIN Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of prescription drugs. The company is known for its emphasis on respiratory and infectious diseases, providing innovative solutions to meet market demands.
Average Trading Volume: 162,224
Technical Sentiment Signal: Sell
Current Market Cap: Yen85.27B
Find detailed analytics on 4569 stock on TipRanks’ Stock Analysis page.